Resverlogix (FRA:RFS) Other Gross PPE: €0.01 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:RFS Resverlogix Corp FRA:RFS
23 GF Score
Price €0.06
! 4 Warning Signs
View Full Analysis

What is Resverlogix Other Gross PPE?

Resverlogix FRA:RFS -5.08% 23 Other Gross PPE is €0.01 Mil as of Jun. 2026. GuruFocus rates FRA:RFS with a GF Score™ of 23/100. The stock has 4 warning signs investors should review.

Resverlogix's Other Gross PPE for the quarter that ended in Jun. 2026 was €0.01 Mil.

Resverlogix's quarterly Other Gross PPE declined from Dec. 2025 (€0.01 Mil) to Mar. 2026 (€0.01 Mil) but then stayed the same from Mar. 2026 (€0.01 Mil) to Jun. 2026 (€0.01 Mil).

Resverlogix's annual Other Gross PPE stayed the same from Dec. 2023 (€0.00 Mil) to Dec. 2024 (€0.00 Mil) but then increased from Dec. 2024 (€0.00 Mil) to Dec. 2025 (€0.01 Mil).

Resverlogix Other Gross PPE Historical Data

* Premium members only.

The historical data trend for Resverlogix's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Resverlogix Other Gross PPE Chart

Resverlogix Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Apr20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.61 0.65 0.00 0.00 0.01

Resverlogix Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.01 0.01 0.01
FRA:RFS
23GF Score
Resverlogix Corp FRA:RFS
Other Gross PPE is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Resverlogix Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Frequently Asked Questions Learn more about Other Gross PPE →
What does a Other Gross PPE of €0.01 Mil mean?
Resverlogix (FRA:RFS) has a Other Gross PPE of €0.01 Mil as of Jun. 2026. Other Gross PPE is property, plant and equipment recorded on a company's balance sheet that not otherwise classified. View historical data on Resverlogix and its competitors.
Is Resverlogix's Other Gross PPE too high?
Resverlogix's current Other Gross PPE is €0.01 Mil. Overall, Resverlogix has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Resverlogix's Other Gross PPE compare to VRTX and REGN?
Resverlogix's Other Gross PPE of €0.01 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Gross PPE for a Biotechnology company?
A good Other Gross PPE depends on the Biotechnology industry context. However, Other Gross PPE should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Gross PPE mean?
A high Other Gross PPE can signal that a stock is expensive relative to its fundamentals. Other Gross PPE is property, plant and equipment recorded on a company's balance sheet that not otherwise classified. View historical data on Resverlogix and its competitors. Resverlogix's current Other Gross PPE is €0.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Resverlogix stock overvalued right now?
Resverlogix (FRA:RFS) has a current Other Gross PPE of €0.01 Mil. The current Other Gross PPE is €0.01 Mil. Resverlogix's overall GF Score™ is 23/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Gross PPE calculated?
Other Gross PPE is calculated from a company's financial statements. For Resverlogix (FRA:RFS), the current Other Gross PPE is €0.01 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Resverlogix Business Description

Other Exchanges RVXCF:USARVX:Canada
Address 4820 Richard Road SW, Suite 300, Calgary, AB, CAN, T3E 6L1
Resverlogix Corp clinical-stage biotechnology company. The company is developing apabetalone (RVX-208), a first-in-class, small molecule that is a selective BET (bromodomain and extra-terminal) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. Apabetalone is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. This selective inhibition of apabetalone on BD2 produces a specific set of biological effects with potentially important benefits for patients with chronic disease, including cardiovascular disease (CVD) and associated comorbidities, and COVID-19.
23GF Score

Get the complete analysis for FRA:RFS

Other Gross PPE is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.06
Price